LDLutfiye Demir

Lutfiye Demir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lutfiye Demir has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Significance of High-Mobility Group A Protein 2 Expression in Pancreatic Ductal Adenocarcinoma and Ampullary Adenocarcinoma

    by Damla Oflas, Funda Canaz, İlTer Özer, Lütfiye Demir, Ertuğrul Çolak

    Background/Aims: Pancreatic and ampullary adenocarcinoma (AAC) are quite resistant to chemotherapy with high metastasis potential. Our study aimed to interpret high-mobility group A protein 2 (HMGA2) expression in benign and precursor pancreatic lesions and pancreatic and ampullary carcinoma and to evaluate its relationship with epithelial–mesenchymal transition (EMT) and clinicopathological parameters. Materials and Methods: In this study, normal-appearing pancreas, chronic pancreatitis (CP), low- (L) and high (H)-grade pancreatic intraepithelial neoplasia (PanIN), pancreatic ductal adenocarcinoma (PDAC), and AAC were evaluated with the immunohistochemical marker of HMGA2. Vimentin and E-cadherin immunohistochemical stains were applied in PDAC and AAC. Results: The HMGA2 expression was not detected in normal-appearing pancreas, CP, and L-PanIN. A statistically significant expression was observed in PDAC and H-PanIN (P < .001). A statistically significant correlation was found between loss of membranous E-cadherin expression and vimentin positivity and HMGA2 expression (P > .05). The HMGA2 expression was observed to increase the risk of diseaserelated death and decrease overall survival (OS) in AAC and the neoplasia group (P = .002 and P = .016, respectively). There was no significant difference in OS and risk of death in PDAC (P > .05) with respect to HMGA2 positivity. Conclusion: High-mobility group A protein 2 is a helpful immunohistochemical marker in differentiating CP from PDAC. It also plays a role in EMT and may serve as a potential new prognostic agent and therapeutic target in tumors of the periampullary region, especially AAC. Cite this article as: Oflas D, Canaz F, Özer İ, Demir L, Çolak E. Significance of high-mobility group A protein 2 protein expression in pancreatic ductal adenocarcinoma and ampullary adenocarcinoma. Turk J Gastroenterol. 2023;34(10):1014-1024.


  • Open Access

    Nivolumab rechallenge after severe immune hepatitis in a metastatic renal cell cancer patient with hepatitis B and no detectable primary

    by Lutfiye Demir, Funda Canaz

    Renal cell carcinoma (RCC) is an aggressive tumor with high metastatic potential and most of cases are determined incidentally on radiologic imaging. Metastatic RCC (mRCC) without a primary is very rare, and only a small number of cases have been reported in the literature. In recent years, immune checkpoint inhibitors have been used to treat mRCC, but they are associated with immune-related adverse events. Immune hepatitis is rare and usually observed within three months of initiation of therapy. Patients with hepatitis B virus (HBV) infection have generally been excluded from immunotherapy trials, although a small number of reports and retrospective studies exist on the use of immunotherapy in patients with HBV infection. A 59-year-old man was diagnosed with mRCC with adrenal and liver metastases and vena cava inferior thrombosis but without evidence of a primary. Second-line therapy with nivolumab achieved a good clinical response, but grade IV immune-related hepatitis was observed after one year. He also had an occult HBV infection. However, HBV reactivation did not occur with continuous entecavir prophylaxis. The hepatitis gradually resolved within two months without any management, and the patient was rechallenged with nivolumab. Metastatic RCC rarely presents without a primary mass in the kidney. In such cases, histologic and immunohistochemical characteristics are critical. Nivolumab-induced immune hepatitis may occur as late as one year after initiation of therapy. Rechallenge of immunotherapy may be considered in selected patients. HBV infection is not a contraindication for immunotherapy, these patients can be treated safely with frequent monitoring and antiviral prophylaxis.


  • Open Access

    A rare case of primary extra-osseous Ewing’s sarcoma presenting in the posterior neck

    by Emre Emekli, Uğur Toprak, Suzan Şaylısoy, Lütfiye Demir

    Tr en Ewing sarkomu, kemik dokusunun Ewing sarkomu, iskelet sistemi dışındaki Ewing sarkomu, periferik primitif nöroendokrin tümör, torakopulmoner bölgenin malign küçük hücreli tümörü (Askin) ve tipik olmayan Ewing sarkomu olarak sınıflandırılır. Ekstraosseöz Ewing sarkomu tüm vücutta görülebilir ancak boyunda %4 oranında bildirilmiştir. Olgumuzda, ensesinde 3 aydır giderek büyüyen ağrısız kitlesi olan hastada; manyetrik rezonans görütülemede perivertebral kasların arasında, yağ planlarının arasında büyüyen, kapsüllü, düzgün sınırlı kitle lezyonu saptandı. Cerrahi olarak çıkarılan tümörde patolojik olarak Ewing sarkomu tanısı koyuldu. Moleküler incelemede 22q11 translokasyonu tespit edildi. Ekstraosseöz Ewing sarkomları nadir olarak görülen yumuşak doku kitleleridir. Görüntüleme özellikleri özgün veya tanı koymada yeterli olmasa da, biyopsi için dokunun uygun yerden alınması ve tümörün evrelendirilmesi açısından önemli yer tutar. Ayrıca iskelet dışındaki Ewing sarkomunda, tam cerrahi rezeksiyonun diğer Ewing sarkomu ailesi tümörlerine kıyasla daha iyi sağkalım oranları ile ilişkili olduğu gösterilmiştir. Bu nedenle cerrahiye yön gösterme ve tümörün çıkarılabilirliğinin değerlendirilmesinde görüntüleme önemli yer tutmaktadır. Hızlı büyüyen, ele gelen kitlesi olan genç hastalarda, ilk planda morfolojik olarak benign izlenimi verse de dikkatle değerlendirip baş-boyun yumuşak doku kitlelerinin ayırıcı tanısında düşünülmelidir. Ewing sarcoma is classified as Ewing’s sarcoma of the bone tissue, extraskeletal Ewing’s sarcoma, peripheral primitive neuroendocrine tumor, malignant small cell tumor of the thoracopulmonary region (Askin) and non-typical Ewing’s sarcoma. Extraosseous Ewing’s sarcoma may be seen throughout the body, however only reported at 4% in the neck. In our case patient has a painless mass growing on his posterior neck for 3 months.On the magnetic resonance imaging, a well-defined, encapsulated, well-demarcated mass lesion between the perivertebral muscles and the subcutaneus fat tissue was detected. Tumor was surgically resected and diagnosis was pathologically Ewing’s sarcoma. 22q11 translocation was detected in the molecular examination. Extraosseous Ewing sarcomas are rarely seen soft tissue masses. Although imaging features are not sufficient to make a specific diagnosis, it is important take the biopsy from the appropriate place and staging the tumor. In addition, complete surgical resection has been shown to associated with better survival rates compared to other Ewing sarcoma family. For this reason, imaging has an important role in the guidance of surgery and resectability of the tumor. Young patients with a fast growing, palpable mass should be evaluated carefully. Although the tumor is thought to be morphologically benign in the first, ekstraosseous Ewing’s sarcoma must be considered in the differential diagnosis of head and neck soft tissue masses.

  • Open Access

    Depression, Anxiety and Sexual Satisfaction in Breast Cancer Patients and their Partners-Izmir Oncology Group Study

    by Ahmet Alacacioglu, Eda Ulger, Umut Varol, Ibrahim Yildiz, Tarik Salman, Vedat Bayoglu, Ahmet Dirican, Lutfiye Demir, Murat Akyol, Yasar Yildiz, et al.

    Depression, Anxiety and Sexual Satisfaction in Breast Cancer Patients and their Partners-Izmir Oncology Group Study Depression;anxiety;sexual satisfaction;breast cancer;Turkey; Background: We aimed to investigate anxiety, depression and sexual satisfaction levels and the effects of depression and anxiety upon the sexual satisfaction of Turkish breast cancer patients and their partners. Materials and Methods: Data were collected from one hundred breast cancer patients and their partners, using three forms: one covering information about socio-demographic characteristics of the patients, the Hospital Anxiety and Depression Scale (HADs) and the Golombok-Rust Inventory of Sexual Satisfaction (GRISS). Results: The frequencies, avoidance and touch subscores were statistically significantly high in the patients. Among those with high anxiety scores, the frequency, communication, satisfaction, touch, and anorgasmic subscale scores of GRISS were found to be significantly high. Among the partners whose anxiety scores were high, only the premature ejaculation subscale was statistically significant. It was determined that for partners with higher depression scores, the communication, satisfaction, avoidance, premature ejaculation and erectile dysfunction subscores of GRISS were statistically higher compared to partners with lower depression scores. Conclusions: Patients' quality of life may be increased by taking precautions to reduce their and their partners' psychosocial and psychosexual concerns.